Intra-Cellular Therapies Inc. buy Morgan Stanley
Start price
11.10.24
/
50%
€69.00
Target price
11.10.25
€86.77
Performance (%)
78.26%
End price
12.10.25
-
Summary
This prediction is currently being closed. The BUY prediction by Morgan_Stanley for Intra-Cellular Therapies Inc. has seen massive gains of 78.26%. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Intra-Cellular Therapies Inc. | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% |
Comments by Morgan_Stanley for this prediction
In the thread Intra-Cellular Therapies Inc. diskutieren
Intra-Cellular Therapies, Inc. (NASDAQ: ITCI) had its price target raised by analysts at Morgan Stanley from $92.00 to $95.00. They now have an "overweight" rating on the stock.
Ratings data for ITCI provided by MarketBeat
In the thread Trading Intra-Cellular Therapies Inc.
Die von Morgan_Stanley gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Morgan_Stanley for Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€53.20
04.08.23
04.08.23
€72.52
04.08.24
04.08.24
28.76%
05.08.24
05.08.24

